Free Newsletter
Medidata plans Mass. blitz
Talk about heading into enemy territory: CTMS solutions maker Medidata, flanked by Almac Clinical Technologies (interactive voice and web response technology) and PHT (electronic patient-reported outcome solutions), journeys to Waltham, MA, later this week on a two-stop tour of breakfast seminars on leveraging clinical trial data. The focus is the Almac/PHT/Medidata data-integration approach for viewing patient data in one system. Waltham, of course, is the seat of power for CTMS archrivals Phase Forward, Perceptive Informatics, and Akaza Research. Release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: